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Introduction
Current evaluation as to whether a chemical is carcinogenic is dependent on the outcome of chronic rodent bioassays, which 30 involves administering the compound at maximum tolerated doses for its lifetime, typically two years. At present, a conventional rodent study takes up to five years, costs €1.5 -3 million per chemical tested and consumes about 800 mice and rats 1 . 35 The last 50 years of animal data suggests that carcinogenic 50 compounds can be divided, based on their mode of action (MOA) into two classes, genotoxic (GTX) and non-genotoxic (NGTX) 2 . GTX carcinogens are readily detected using a number of shortterm bacterial and cultured mammalian cell assays and although these assays are very sensitive, a problem of low specificity exists 55 [3] [4] [5] .NGTX carcinogens, however, are more problematic and depend in most cases on the outcome of a two-year rodent bioassay. Although some in vitro tests are available 6 , currently there is no accurate in vitro model that can predict the carcinogenic potential of NGTX chemicals. Each year, several 60 thousand new chemicals are entering the world markets and additionally under the Registration, Evaluation, Authorization and restriction of Chemicals (REACH) initiative there is a need to validate the toxicity of an estimated 68,000 chemicals 7 . Highthroughput technologies such as whole-genome gene expression 65 profiling have opened the way to understand the systemic response to a toxic insult and also might speed up the process of risk assessment [8] [9] . In this study, the Normal Rat Kidney Epithelial cell line (NRK-52E) was exposed to eleven carcinogens and five non-70 carcinogens (NC) at their IC10 concentration at 72h for 6h, 24h and 72h. The selected renal carcinogens, all known to induce cancer in rats, were classified based on their presumed MOA into GTX, NGTX and NC classes 10 . From the selected GTX compounds, two have been classified by International Agency for Research on Cancer (IARC) as carcinogenic to human (Group 1), 5 aristolochic acid and benzo(a)pyrene. One, dimethylnitrosamine to Group 2A, probable human carcinogen, and three, 2-nitrofluorene, streptozotocin and potassium bromate to Group 2B, possible human carcinogen. The five NGTX carcinogens selected for this study are all chlorinated chemicals. Three of them, 10 bromodichloromethane, chlorothalonil and ochratoxin A are classified as Group 2B while monuron is classified as Group 3, not carcinogenic to humans. S-(1,2-dichlorovinyl)-L-cysteine is a non-classified metabolite of trichloroethylene (which itself belongs to Group 2A). As a control five NC, mainly widely used 15 pharmaceuticals, clonidine, D-mannitol, diclofenac sodium, nifedipine and tolbutamide were used. Many GTX carcinogens undergo some degree of metabolism in order to interact with DNA [11] [12] . NRK-52E cells have poor cytochrome P450 drug metabolising capability 13 (HPLC-MS/MS; Bloch, unpublished 20 results), so additional studies were conducted with and without pre-incubation with rat liver β-naphthoflavone-induced S9 fraction. After 6h, 24h and 72h of exposure the total RNA was isolated, purified, quality checked and whole-genome gene expression changes were determined using Affymetrix Rat 25 GeneChip 230 2.0. In addition to alteration in transcriptome profile, DNA damage was determined by conducting the cytokinesis-blocked micronucleus assay 14 .
Materials and Methods

Chemicals
30
All test chemicals were purchased from Sigma-Aldrich, UK, except for S-(1,2-dichlorovinyl)-L-cysteine which was a gift from D. Moore, formerly of Syngenta Central Toxicology Laboratory, Alderley Park, Cheshire. β-naphthoflavone-induced rat liver S9 was purchased from Celsis, In Vitro Technologies, Belgium.
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Cell culture
NRK-52E cells (ATCC, CRL-1571) were cultured in Dulbecco's Modified Eagle Medium (DMEM) with 10% fetal calf serum and penicillin 100 I.U./ml, streptomycin solution 100 µg/ml in a humidified 5% CO2 incubator at 37 0 C. For cytotoxicity and 40 transcriptomics studies, cells were sub-cultured in 6-well plates in medium without serum until 80% confluent and then exposed to selected compounds dissolved in DMSO (0.1%v/v) or medium (in case of potassium bromate).
Generation of IC10
45
A dose-response curve for cytotoxicity using LDH leakage and the MTT assay 15 was generated for each compound after 24h and 72h exposure using cells exposed to medium or DMSO alone as the 100% value. At least three separate experiments were conducted with each compound. The dose that caused 50 approximately 10% cytotoxicity (IC10) at 72h was selected for the transcriptomics studies. The doses selected were as follows: GTX compounds; 1.65μM, aristolochic acid (AA); 40μM, benzo(a)pyrene (BaP); 20μM, 2-nitrofluorene (2NF) and 500μM, potassium bromate (KBrO3).
NGTX compounds; 470μM,
monuron (MON) and 0.5μM, ochratoxin A (OTA). NC compounds were; 1.12mM, clonidine (CLO); 6μM, diclofenac sodium (DS); 35μM, nifedipine (NIF) and 370μM, tolbutamide 60 (TOL). The GTX compounds; dimethylnitrosamine (NDMA), streptozotocin (STZ) and NC; D-mannitol (MAN) were not cytotoxic to NRK-52E cells and used at a dose of 1mM, 5mM and 10mM respectively. After 6h, 24h and 72h the medium was removed and the cells taken for RNA extraction, three studies 65 were conducted at each time point with each compound.
Incorporating an enhanced xenobiotic capability
The IC10 concentration for three GTX compounds was determined in the presence of S9 over 72h as described above. The IC10 concentrations were as follows: BaP (87µM), STZ 70 (350µM) and 2NF (70µM). Compounds were pre-incubated in either the presence or absence of rat liver β-naphthoflavoneinduced S9 metabolising system for 3h at 37 0 C. The S9 metabolising system was prepared by diluting the S9 fraction to 10mg protein/ml with ice-cold Tris buffer, (60mM, pH 7.4). The 75 NADPH regenerating system consisted of ice-cold NaHCO3 (2% (w/v), NADP + (1.7mg/ml), glucose-6-phosphate (7.8mg/ml) and glucose-6-phosphate dehydrogenase (6units/ml) which was prepared immediately before use. The reaction mixture contained S9 fraction 10mg/ml (0.1ml), 60mM Tris buffer, pH 7.4 (0.64ml), 80 NADPH regenerating system (0.25ml) and the reaction was started by the addition of DMSO or tested compound dissolved in DMSO (0.01ml). The reaction was stopped after 3h by heating to 60°C then cooled on ice and added to ~80% confluent NRK-52E cells growing in 1ml medium in 6 well-plates. After 72h the 85 medium was removed and the cells taken for RNA extraction, with three studies conducted with each compound.
Cytokinesis -Block Micronucleus Assay
NRK-52E cells were seeded on glass slides and exposed to GTX or NGTX compounds at the IC10 concentration at 72h together 90 with cytochalasin B (3µl/ml of a 1mg/ml stock solution in DMSO) in 1ml medium for 24h. Compounds were dissolved in DMSO, with the exception of KBrO3 which was dissolved in medium. The cells were fixed with 37% (v/v) formaldehyde (0.1ml) in hypotonic solution (0.4% Na-citrate/0.4% KCl 1:1 95 v/v)(2.4ml) and incubated for 8 min at 4°C. The cells were then washed with a solution containing equal volumes of hypotonic solution (Na citrate/KCl) and fixative (methanol (100%): acetic acid (100%) 4:1v/v). Then 50% of the hypotonic/fixative mixture was removed and fixative alone was gently added. The mixture 100 was then removed and 100% fixative was added and left for at least 3 min. The slides were than air-dried and immersed for 15 min in 10μM DAPI solution in distilled water. After air-drying the slides were mounted with a cover slip for microscopy. Around 3,000 binucleated cells from at least three replicates were 105 analyzed for the presence of micronuclei (MN) using an automated MN scoring system Metafer (MetaSystems). Control cells with DMSO (or medium alone) were compared to treated cells. For some studies, the cells were pre-incubation with rat liver S9 fraction either alone or in the presence of a GTX 110 carcinogen as described above. Statistical analysis was performed between the relevant control and test compound using a paired t-test (GraphPad InStat) with a p value <0.05 considered significant.
RNA isolation and microarray
Total RNA was isolated from control and compound treated NRK-52E cells with trizol reagent (Invitrogen) and purified using 5 the RNeasy Total RNA Mini Kit (Qiagen) according to manufacturer's instructions. Purified total RNA was checked for purity and integrity using a Agilent 2001 Bioanalyzer (Agilent Technologies GmbH, Germany) before processing. All RNA used in this study had values of 1.9-2.0 as measured by A260/A280 10 ratio, and RIN values from 9-10. The integrity of RNA was also checked by gel electrophoresis with result showing a clear 2:1 ratio of 28S rRNA to 18S rRNA. The amount of RNA was around 1-5μg. Transcriptomics data was generated using Affymetrix GeneChip Rat Genome 230 2.0 Arrays. 15 Three replicates were used for each compound and control and at each time point..
Microarray Hybridization
Target preparation cDNA was prepared using the Affymetrix IVT express kit 20 (Affymetrix, Santa Clara). cDNA synthesis and labelling was performed according to the manufacturer's procedures. Subsequent labelling of the samples was conducted by synthesis of Biotin-labelled complementary RNA (cRNA) using the GeneChip IVT labelling kit (Affymetrix). Purified cRNA was 25 quantified using a spectrophotometer, and unfragmented samples were checked on the Bioanalyzer. Subsequently, cRNA samples were fragmented for target preparation according to the Affymetrix manual and checked on the Bioanalyzer. Samples were stored at −20°C until ready to perform hybridization. 
Microarray analysis
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The intensity values of different genes (probe sets) generated by Affymetrix GeneChip Operating Software were imported into Genedata Expressionist® version 7.0 and GeneSpring version 11 software (Agilent), respectively, for data analysis. The raw data files (.CEL files) containing signal values for individual probes 50 were pre-processed to generate one value per probeset. Preprocessing of arrays was done using GC-RMA (Robust Multiarray Analysis algorithm). To identify the differentially expressed genes, the condensed data were subjected to pairwise comparisons, using paired t-test. Comparisons were made 55 between control and treated samples. Only genes with >2-fold change, using a p < 0.001 threshold value were analyzed.
Functional annotation
To understand the biological meaning behind the list of differentially expressed genes, KEGG (Kyoto Encyclopaedia of 60 Genes and Genomes database) pathways analysis and GO (Gene Ontology) from DAVID website (The Database for Annotation, Visualization and Integrated Discovery) v 6.7 was used (http://david.abcc.ncifcrf.gov/) 16 . The list of differentially expressed probe sets (DEPs) obtained from the 65 GeneSpring v.11 was uploaded and run for enriched GO and KEGG pathways. Only GO and pathways with p <0.05 were analysed and discussed.
Results
Selection of exposure dose
70
These studies was aimed at detecting the early carcinogenic potential of eleven renal carcinogens in vitro, thus NRK-52E cells were exposed to a single dose that caused 10% cytotoxicity (IC10) at 72h. Three exposure time points were selected 6h, 24h and 72h exposure effects. Cytotoxicity studies showed that 81% of the 75 selected compounds (13/16) were cytotoxic to NRK-52E cells, the cytotoxicity being time and dose-dependent. All NGTX compounds were toxic to NRK-52E cells, whereas two compounds from the GTX group (STZ and NDMA) and one from the NC group (MAN) exhibited no cytotoxicity at the highest 80 concentration tested. The most toxic compounds were OTA followed by CHL > AA > DCVC > DS > BaP > NIF > 2NF > MON > TOL > BDCM > KBrO3 > CLO. In addition to cytotoxicity, the in vitro cytokinesis-block micronucleus assay was used to assess if the dose used had any effect on DNA. The 85 assay confirmed the lack of clastogenicity with NGTX compounds, as none of the five NGTX compounds induced micronuclei (MN) formation (Table 1 ). In the GTX group chromosomal damage was increased with KBrO3, AA and BaP (Table 1 ). In addition, MN formation was examined after 90 exposure to three GTX compounds BaP, 2NF and STZ in the presence of a rat liver β-naphthoflavone-induced S9 drug metabolising system. S9 alone after heat-incubation step caused 10% cytotoxicity CHECK IT. A statistically significant increase in MN formation was seen after exposure to BaP in the presence 5 of S9 (Table 1) , while in the absence of S9 there was a small increase which was not statistically significant (Table 1) . There was a trend for an increase in MN formation with 2NF and STZ in presence of S9 but this was not statistically significant (Table  1) . 
Cd55 (Decay accelerating factor for complement 5)
Transcriptomics studies
Transcriptome analysis revealed that the response of the NRK-52E cells to GTX carcinogens and NC compounds was far less pronounced than to NGTX carcinogens ( Table 2) . BDCM (NGTX) and NDMA (GTX) had a marginal effect on the 25 transcriptome profile and as both compounds were volatile at 37 0 C, the exact exposure concentration was uncertain and thus both chemicals were not included in the analysis. In total, transcriptomic analysis has been conducted on five GTX carcinogens, four NGTX carcinogens and five NC compounds. 30 Exposure to the five GTX carcinogens altered 214 genes in total over 6h, 24h and 72h, while exposure to the five NC altered a total of 271 genes. In contrast, exposure to the four NGTX carcinogens altered the expression of > 4,000 genes ( Table 2 ). In agreement with previous studies, there was generally a time- 35 dependent increase in the number of differentially expressed genes [17] [18] .
Carcinogenic versus non-carcinogenic compounds
There were no common genes altered by all of the renal carcinogens (GTX+NGTX), including the three GTX compounds tested in the presence of a S9 metabolising system. However, three genes Mdm2 (MDM2 p53 binding protein), p21 (Cyclindependent kinase inhibitor 1) and Cd55 (Decay accelerating 5 factor for complement), were commonly altered by 6 out of 9 compounds (67%) in case of Mdm2 and by 5 out of 9 compounds (56%) in case of p21 and Cd55 (Table 3 ). The deregulation primarily occurred at the later time point (Table 3 ). In addition, Aqp1 (Aquaporin 1) was altered by two GTX and two NGTX 10 compounds after 72h exposure (Table 3) . None of these genes were altered at any time point by the five NC compounds.
Non-genotoxic compounds
. No commonly deregulated genes were induced by all four NGTX carcinogens at 6h, 24h or 72h. However, five genes with 15 the same pattern of expression (except Usp9x) were commonly deregulated after 72h exposure to CHL, DCVC and OTA namely: Lingo1 (Leucine rich repeat and Ig domain containing 1), Hmox1 (Heme oxygenase, decycling 1), Ssu72 (Ssu72 RNA polymerase II CTD phosphatase), Lyrm1 (LYR motif containing 1) and 20
Usp9x
(Ubiquitin specific peptidase 9, X-linked) (Table 4) . 
Genotoxic compounds
75
. In the GTX class there were no commonly genes identified at any time point with AA, BaP, 2NF, STZ and KBrO3 or BaP, STZ or 2NF in the presence of S9. AA was the only compound (from the GTX without S9) that enriched cancer related pathways (Table 2 ). BaP and 2NF had a 80 very small effect on the transcriptome profile, whereas exposure to KBrO3 altered 66 genes over 72h ( in cancer-related pathway were altered in the presence of S9. AA was not studied in the presence of S9 as nitro-reduction is primarily involved in the activation while oxidation via CYP1A1 has been shown to protect against the carcinogenic effect of AA 20 . In general, exposure to GTX compounds (BaP, 2NF and 5 STZ) together with induced S9 increased the number of DEPs and helped to predict their carcinogenic potential (Table 5) .
Five genes with the same pattern of expression were found to be commonly deregulated by BaP, 2NF and STZ after prior external metabolic activation; Mgmt (O-6-methylguanine-DNA 10 methyltransferase), Epoh1 (Epoxide hydrolase 1), Scarb2 (Scavenger receptor class B, member 2), Jam3 (Junctional adhesion molecule 3) and Cd55 (Table 6 ). However, from these five deregulated genes, three were also deregulated by NGTX carcinogens. Cd55, in addition to being down-regulated by BaP, 15 STZ and 2NF after metabolic pre-incubation, was also downregulated by KBrO3 and by the NGTX carcinogen OTA, whereas Mgmt and Scarb2 were up-regulated by DCVC exposure. Thus it is much more difficult to find a set of specific genes deregulated by the GTX carcinogens. 20 In addition, no commonly deregulated genes were found to be altered by GTX carcinogens exposure, that were positive for MN induction (AA, KBrO3 and BaP/S9) after 72h exposure. BaP exposure after metabolic activation (BaP/S9) increased of number of DEPs and significantly enriched pathways associated with cancer such as the MAPK signalling and focal adhesion (Table 5 ). STZ after metabolic activation (STZ/S9) also increased the number of DEPs as compared to STZ alone and significantly 35 enriching the p53 signalling pathway (Table 5) . Results with 2NF were more ambiguous, with a slight increase in the number of DEPs and enrichment of more diverse set of pathways including cancer pathways.
Discussion
40
The rat renal normal epithelial cell line (NRK-52E) was selected for this work with the main aim being to find an alternative model system to classify compounds according to their carcinogenic potential to the kidney. As the majority of the current carcinogenic data derives from rodents (mainly rats), NRK-52E 45 cells were the preferred cell line. The current evaluation of carcinogenicity of chemicals relies heavily on different animal in vivo and in vitro methods, with NGTX carcinogens being especially problematic. In this work eleven chemicals that cause renal tubule tumours in 50 rats have been evaluated. Six of them have previously been shown to act via a GTX mechanism and five chemicals are thought to act by a NGTX mechanism 10 . Additionally five NC had been used as controls. Cytotoxicity studies were conducted using all 16 chemicals on NRK-52E cells, to assess the effect that 55 these chemicals had on the cells. Determination of cytotoxicity is an initial step toward the characterisation of chemicals. Although cytotoxicity assays per se does not provide mechanistic data, they shed light on cell response/susceptibility to investigated cytotoxins. Furthermore, knowledge of the 60 concentration range that induces cytotoxicity enables better definition of concentrations to be employed in more in-depth descriptive and mechanistic studies such as gene expression profiling. As the main aim of the project was to try to detect an early carcinogenic potential of the selected compounds, the 65 endpoint of interest was carcinogenicity not cytotoxicity, the selected dose that cause only 10% cytotoxicity (IC10) and thus have small but visible effect on the cell line was used. For transcriptomics, only one dose was investigated, but with different times of exposure. The reason for this being the analysis 70 of previous published studies, showing that in in vitro models, treatment time has a much larger impact on gene expression than the chemical's dose [21] [22] . Three time points were selected to provide additional data 6h, 24h and 72h . The early exposure time point (6h) was selected as GTX chemicals have been shown to 75 induce DNA damage and repair in a matter of few hours after administration [23] [24] . As the main aim of this study was to look at the carcinogenicity of the chemical and 1/3 of the chemicals used are known to be DNA-reactive, the in vitro micronucleus assay was used to assess if the dose used (IC10) had any effect on 80 DNA. The assay confirmed the lack of clastogenicity with NGTX chemicals (Table 1 ). In the GTX group, chromosomal damage was proven for KBrO3, AA and BaP. The clastogenicity after KBrO3 exposure is believed to be due to oxidative stress, increased reactive oxygen species, glutathione depletion 25 and 8-85 OHdG formation leading to double strand breaks in the DNA [26] [27] . AA has also been shown to increase MN formation in mouse bone marrow cells 28 , human lymphocytes exposed to the plant extract from Aristolochia 29 and HepG2 cells 30 . A small, but statistically significant, induction of MN was seen with BaP 90 (Table 1) . BaP is known to require metabolism by cytochrome P450 to undergo metabolic activation 31 and as NRK-52E cells do not possess functional cytochrome P450 (as quantified by HPLC-MS/MS with a range of different substrates, Bloch, unpublished results) this finding was unexpected, but may be explained by 95 photoactivation of the chemical 32 . A statistically significant increase in MN formation was observed after the addition of a xenobiotic drug metabolising system in case of BaP and a small but not statistically significant increase was noted after 2NF/S9 and STZ/S9 (Table 1) .
Carcinogen detection
Although it was not possible to find a set of genes that was commonly deregulated by all five GTX carcinogens and by all four NGTX carcinogens, Mdm2, p21 and Cd55 were commonly altered by five or more carcinogens (Table 3) . Mdm2 and p21 5 were proposed by Ellinger-Ziegelbauer 33 as a gene signature for GTX exposure in rat liver, however we observed that CHL, OTA and DCVC also altered the expression of the aforementioned genes (Table 3) . CD55 is one of the complement regulatory/inhibitory proteins and is altered in a wide range of 10 solid tumours 34 . Interestingly Aqp1 was also altered by GTX and NGTX carcinogens and recently Aqp1 has been proposed as a renal cancer biomarker 35 . Additionally examination of pathways enriched by chemical exposure, showed that 3 out of 4 (75%) NGTX carcinogens and 4 15 out of 5 (80%) GTX carcinogens (AA, BaP/S9, 2NF/S9, STZ/S9, with KBrO3 being the only chemical that did not enriched any pathway) were related to known pathways involved in carcinogenesis. In contrast, none of the NC chemicals induce any of the well-established carcinogenic pathways. Mannitol and 20 BaP/S9 both increased 4 and 5 genes respectively in the focal adhesion pathway, however there was only one common gene coll1α1. So far gene expression profiling studies using cancer related pathways has shown a detection rate of 78% for renal carcinogens (7/9) under the conditions of these studies. 25 The enriched pathways that were affected by two or more carcinogens include; p53 signalling pathway (AA, 2NF/S9, STZ/S9, DCVC and OTA), pathways in cancer (AA, BaP/S9, CHL, DCVC and OTA), cell cycle (2NF/S9, DCVC and OTA), focal adhesion (BaP/S9, CHL and DCVC), MAPK signalling 30 pathway (BaP/S9 and CHL). Thus, this study has shown that NRK-52E, rat renal cell model has a potential for detecting renal carcinogens in vitro. MON was the only NGTX compound that did not altered any canonical cancer related pathways. However, using a less stringent p value of <0.01 MON increased pathways 35 in cancer, renal cell carcinoma and the cell cycle 72h after exposure.. As mentioned above there is a real problem of early detection of NGTX carcinogens. In NRK-52E cells, exposure to three of the four compounds (except for MON) commonly deregulated five 40 genes, Lingo1, Hmox1, Ssu72, Lyrm1 and Usp9x (Table 4) 36 . Lingo1 is currently implicated in oligodentrocyte differentiation and axonal myelination and no study so far have shown its involvement in carcinogenesis. HMOX1 which is under the regulation of Nrf2, plays an important role in oxidative injury 37 45 and has been shown to regulate cell proliferation, modulate inflammatory response and facilitate angiogenesis 38 . Ssu72 encodes a protein involved in RNA processing and termination. Little is known about the function of LYRM1, although Qiu et al. 39 has shown that the protein is involved in modulation of cell 50 growth and apoptosis in pre-adipocytes. USP9X is a member of the peptidase family that regulate the production and recycling of ubiquitin which are involved in the control of cell growth, differentiation and apoptosis 40 . NGTX carcinogens predominantly up-regulated genes involving in signalling 55 pathways, whereas genes involved in metabolism were predominantly down-regulated.
This finding agrees with studies analysing gene expression in human clear cell renal carcinoma, where loss of normal renal function, downregulation of metabolic genes and alteration in 60 multiple canonical cancer-associated pathways occurs, including cell cycle, focal adhesion, ECM-interaction and disruption in amino-acid metabolism [41] [42] . Additionally as mentioned above three NGTX carcinogens commonly deregulated the cell cycle pathway with common deregulation of genes from the GADD45 65 family. Proteins encoded by these genes are DNA-damaging sensor proteins, with up regulation of expression after a DNAdamaging event. They interact with both CDK1 (Cyclindependent kinase 1) and CCNB1 (Cyclin B1), resulting in inhibition of the kinase activity of the CDK1/CCNB1 complex, 70 and function as a negative growth control. In addition, all three NGTX deregulated different cancer pathways such as WNTsignalling, renal cell carcinoma pathway, mTOR pathway and MAPK signalling pathway ( Table 2) . GTX compounds, except from AA, without prior metabolic 75 activation altered a much smaller number of genes as compared to NGTX compounds and did not alter cancer related pathways. Thus an external metabolising system was used to improve the metabolic capabilities of the NRK-52E cells. Pre-incubation with an induced rat liver S9 fraction was shown to improve the 80 detection of carcinogenic potential of GTX compounds (Table 5) . Following BaP/S9, 2NF/S9 and STZ/S9 exposure five genes were found to be commonly deregulated; Mgmt, Scarb2, Epoh1, Jam3 and Cd55 (Table 6) . Mgmt encodes an enzyme that repairs alkylated guanine in DNA. STZ is a known alkylating agent, 85 while BaP and 2NF are not, however Ellinger-Ziegelbauer and coworkers reported an increase in Mgmt after in vivo exposure to 2NF and other GTX compounds 43 . While Grombacher and coworkers showed that p53 regulates Mgmt expression and that Mgmt is induced after GTX stress, being one of the first DNA 90 repair gene to be up-regulated 44 . Epoh1 is a critical enzyme in xenobiotic detoxification, which catalyzes the hydrolysis of arene and aliphatic epoxides to less reactive and more water soluble dihydrodiols. However, EPOH1 has been shown to activate BaP to mutagenic and carcinogenic products and Epoh1 95 polymorphisms have been associated with the onset of numerous cancers [45] [46] [47] . Scarb2 encodes a transmembrane glycoprotein that is located in lysosome and endosome membranes and may participate in membrane transportation and the reorganization of endosomal/lysosomal compartments. Huang and coworkers 100 reported the loss of heterozygosity in Scarb2 in human hepatocellular carcinoma 48 . Jam3 encodes a protein that is expressed in close proximity to tight junctions of polarized endothelial and epithelial cells and also mediates cell adhesive events between tumour cells and the endothelium 49 .
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In addition, cancer-related pathways were also enriched with induction of the p53 signalling pathway after STZ/S9 and 2NF/S9 exposure and MAPK signalling after BaP/S9 exposure. Enrichment of MAPK signalling pathway after BaP exposure has also been reported by others [50] [51] [52] . MAPK signalling pathway was 110 also enriched after 6h exposure to CHL (NGTX), although only one gene Gadd153 was commonly up-regulated by both compounds. Although the addition of the S9 fraction greatly improved the response to BaP and STZ, with 2NF/S9 the results were more ambiguous. 2NF (40μM) alone altered 6 genes over 72h, however increasing the dose to 70μM led to 87 genes being altered while the addition of S9 to 2NF (70μM) led to 110 genes being altered. This suggests in the case of 2NF that the dose was more important than metabolic pre-incubation. However, closer examination revealed that although the higher concentration 5 induced more DEPs, the DE genes altered after exposure to 2NF alone were involved in apoptosis in contrast to 2NF/S9 exposure where the genes were primarily involved in metabolism (amino acid transport, amino acid activation and cholesterol biosynthesis). In addition, there were some similarities after exposure to 2NF (70μM) with and without S9; ten commonly deregulated genes associated with cancer and a significant enrichment of the p53 signalling pathway. In addition, exposure to 2NF/S9 enriched four pathways namely aminoacyl-tRNA biosynthesis, glycine, serine and threonine metabolism and 15 porphyrin metabolism, all being down-regulated (Table 5 ). the list of all differentially expressed genes induced by exposure to the four NGTX carcinogens, at the three time points and the six GTX carcinogens with and without previous metabolic activation at the three time points were pooled, pathway enrichment analysis showed that there was no major differences 35 between these two groups (Tables 7 and 8 ). In general, the pathways affected by GTX carcinogens were also affected by NGTX carcinogens, although not all pathways enriched by NGTX were enriched after GTX exposure. The unaffected pathways were mainly intermediary metabolism pathways for 40 amino acids, carbohydrates and lipids. This may be explained by a more diverse MOA and thus the larger number of genes affected after NGTX exposure. The motivation behind classification into GTX and NGTX class is risk assessment based. NGTX carcinogens are thought to be less hazardous to human 45 health than GTX, with a threshold for NGTX exposure and no threshold value for GTX carcinogen exposure. However, some studies have suggested that there might also be a threshold for GTX exposure [53] [54] . This study using NRK-52E cells has demonstrated that it is difficult to separate GTX from NGTX 50 carcinogens. This might be due to incorrect classification of a compound(s) e.g. OTA 55 , inherent limitation of the in vitro model system used, or the small number of compounds tested. Despite these limitations, the data presented here shows that gene expression profiling in NRK-52E cells is a promising model tool 55 which used in conjunction with an external metabolising system can provide valuable information on the potential carcinogenicity of chemicals. In summary, we have been able to detect renal carcinogens using pathway analysis with a success rate of 78% for 9 carcinogens, 60 using an S9 drug metabolising system for the GTX compounds. In addition we could clearly separate these carcinogens from 5 NC. With regard to separating GTX from NGTX carcinogens we identified several common pathways for both classes, making it difficult to separate direct acting carcinogens from the indirect 65 acting of carcinogens.
